Antiproliferative effect of lonidamine on a human glioblastoma multiforme cell line. 1990

F Iacopino, and G Sica, and P Macrì, and M G Paggi, and M Scerrati, and R Roselli, and P Marchetti, and G R Della Cuna, and L Marini
Istituto di Istologia ed Embriologia Generale, Università de L'Aquila, Pavia, Italy.

Recent data from phase II trials have shown that lonidamine (LND) is effective in the treatment of tumors of various histogenesis, including gliomas. In the present work, we tested the antiproliferative effect of LND on a human glioblastoma cell line (LI) in different culture conditions. When LI are cultured in their standard conditions, a reduction of cell growth is seen after 3 days of treatment with 10(-4) M LND. It reaches 70% with respect to control after 6 days and is statistically significant. LND is ineffective at the other concentrations tested. In more stringent culture conditions, 10(-4) M LND determines a higher inhibition of cell proliferation both after 3 and 6 days of exposure, while other doses of LND are unable to affect cell growth.

UI MeSH Term Description Entries
D007191 Indazoles A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES. Indazole
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

F Iacopino, and G Sica, and P Macrì, and M G Paggi, and M Scerrati, and R Roselli, and P Marchetti, and G R Della Cuna, and L Marini
January 2019, Medical journal of the Islamic Republic of Iran,
F Iacopino, and G Sica, and P Macrì, and M G Paggi, and M Scerrati, and R Roselli, and P Marchetti, and G R Della Cuna, and L Marini
May 2014, Experimental and therapeutic medicine,
F Iacopino, and G Sica, and P Macrì, and M G Paggi, and M Scerrati, and R Roselli, and P Marchetti, and G R Della Cuna, and L Marini
January 2018, Journal of cancer research and therapeutics,
F Iacopino, and G Sica, and P Macrì, and M G Paggi, and M Scerrati, and R Roselli, and P Marchetti, and G R Della Cuna, and L Marini
December 1984, The Bulletin of Tokyo Medical and Dental University,
F Iacopino, and G Sica, and P Macrì, and M G Paggi, and M Scerrati, and R Roselli, and P Marchetti, and G R Della Cuna, and L Marini
September 2021, Oncology research,
F Iacopino, and G Sica, and P Macrì, and M G Paggi, and M Scerrati, and R Roselli, and P Marchetti, and G R Della Cuna, and L Marini
May 1998, Cancer genetics and cytogenetics,
F Iacopino, and G Sica, and P Macrì, and M G Paggi, and M Scerrati, and R Roselli, and P Marchetti, and G R Della Cuna, and L Marini
March 2024, Anatomy & cell biology,
F Iacopino, and G Sica, and P Macrì, and M G Paggi, and M Scerrati, and R Roselli, and P Marchetti, and G R Della Cuna, and L Marini
January 2016, Journal of cancer research and therapeutics,
F Iacopino, and G Sica, and P Macrì, and M G Paggi, and M Scerrati, and R Roselli, and P Marchetti, and G R Della Cuna, and L Marini
May 2024, Asian Pacific journal of cancer prevention : APJCP,
F Iacopino, and G Sica, and P Macrì, and M G Paggi, and M Scerrati, and R Roselli, and P Marchetti, and G R Della Cuna, and L Marini
February 2000, Neuropathology and applied neurobiology,
Copied contents to your clipboard!